Oncology Pharmacy News

In light of Covid-19 there have been some mitigation strategies implemented either nationally or within local hospitals. As a group of clinical academics based at University College London we are interested in understanding the approach your institution has taken regarding the care of cancer patients, in terms of the policies/practice regulations which have been issued and how these have been translated into practice. We believe you can help shed light on this.


By Felice Musicco, Instituti Fisioterapici Ospitalieri, Italy

In general, the use of drugs is desirable, taking into account risks and benefits, always within controlled trials, in order to produce valid results and, above all, to produce therapeutic recommendations.


By Shaun O'Connor, St. Vincent's Health, Australia

Over 800 pharmacists gathered at Royal Seginus Hotel, Antalya, Turkey for the 7th TÜKED Congress.


By Lorraine Diwas and Margarita Padilla, Inpatient Pharmacy, Cleveland Clinic Abu Dhabi, United Arab Emirates

The Cleveland Clinic Abu Dhabi (CCAD) is a multi-specialty hospital located in Abu Dhabi, United Arab Emirates that has been open to the public since May 2015.


By Hisanaga Nomura, Japan Agency for Medical Research and Development, Japan 

Until only 10 years ago, the main types of cancer treatment used to be referred to as “The Three Musketeers,” which were surgery, chemotherapy, and radiotherapy. Since Check-Mate 037 was published, cancer treatment has now expanded to four pillars, to also include immunotherapy.


By Tiene Bauters, Ghent University Hospital, Pharmacy, Belgium

Tackling exposure to carcinogen, mutagen and reprotoxic substances in both workplaces and the wider population is a core competency of the European Union. 


You are being invited to take part in an MPharm final year project. The primary aim of this study is to understand the perceptions and knowledge of oncology pharmacy practitioner’s on assisted dying.


The Clinical Oncology Society of Australia (COSA) is a multidisciplinary society for health professionals whose work involves the care of cancer patients. An Annual Scientific Meeting (ASM) is held each November, and the 2019 ASM was held in sunny Adelaide, South Australia, at the Adelaide Convention Centre. The theme for the ASM was ‘Putting Precision and Personalisation into Practice’ and focussed on urogenital cancers, age and gender in cancer practice, and digital health in cancer.


In 2014, I gained an exciting job in a cancer center in Accra-Ghana. I was a young newly qualified pharmacist, and cancer was an emerging disease trend in Ghana and across Africa. I felt truly privileged to be amongst the few Pharmacists helping to combat this disease state. Being the only female Pharmacist in the practice at the time was also such a privilege.


By Esin Aysel Kandemir, Turkish Medicines and Medical Devices Agency